Top Markets
#1 Derive Derive +15.92%
#2 Cross Cross +14.63%
#3 Glidr Glidr +10.10%
#4 Gama Token Gama Token +9.10%
#5 Based Based +5.46%
#6 Talus Network Talus Network +5.41%
#7 龙虾 (Lobster) 龙虾 (Lobster) +4.95%
#8 Cap Cap +4.91%
#9 TDCCP TDCCP +4.76%
#10 LEO Token LEO Token +4.69%
Coin of the day
Derive Derive
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR
Peringkat dalam Saham #36561
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Harga Saham
$1.73
Terakhir disinkronkan: 2025-06-17
Kapitalisasi Pasar
$2.55M
Perubahan (1 hari)
-0.29%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Eiger BioPharmaceuticals, Inc. (EIGR)

Kategori

Healthcare
Riwayat hasil dividen untuk Eiger BioPharmaceuticals, Inc. (EIGR)
Hasil dividen (TTM) dari Eiger BioPharmaceuticals, Inc. (simbol saham: EIGR) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Eiger BioPharmaceuticals, Inc. (EIGR) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE